| Budget Amount *help |
¥16,640,000 (Direct Cost: ¥12,800,000、Indirect Cost: ¥3,840,000)
Fiscal Year 2020: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2019: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2018: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
|
|---|
| Outline of Final Research Achievements |
The cause and progression of Alzheimer disease (AD) still remain uncertain, while pathological interaction of AD with lifestyle diseases, including hypertension and diabetes, has been suggested in clinical settings.
Our present findings indicate that several vascular endothelial specific Non-coding RNA might be responsible for the molecular and pathological interaction of AD with hypertension, and thereby will be new therapeutic targets against AD as well as lifestyle diseases.
|
